Pharmacorp Rx Inc. (TSE:PCRX) has released an update.
PharmaCorp Rx Inc. has successfully completed the acquisition of a pharmacy in Atlantic Canada, with the transaction costing $15.377 million, paid partly in cash and through issuing common shares. This strategic move includes not only the pharmacy business but also its associated land and buildings, significantly bolstering PharmaCorp’s presence in the region.
For further insights into TSE:PCRX stock, check out TipRanks’ Stock Analysis page.
